Literature DB >> 9259457

Autoradiographic localization of [3H]nociceptin binding sites from telencephalic to mesencephalic regions of the mouse brain.

S Florin1, I Leroux-Nicollet, J C Meunier, J Costentin.   

Abstract

The binding sites of [3H]nociceptin (also named Orphanin FQ), the endogenous ligand of the ORL1 (opiate receptor like 1) receptor, were localized in the central nervous system of the mouse using an autoradiographic procedure. A high density of binding sites was seen in the cerebral cortex, paraventricular nucleus of the thalamus, amygdaloid complex, suprachiasmatic nucleus, medial thalamus and medial geniculate nucleus. Moderate binding was observed in the nucleus accumbens, lateral septum, lateral thalamus, hippocampus, periaqueductal grey matter and pons. Finally, low levels of binding were seen in the striatum, olfactory tubercle, hypothalamus and substantia nigra. Thus, it appears that the ORL1 receptor is particularly abundant in the cerebral cortex and limbic system of the mouse brain.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9259457     DOI: 10.1016/s0304-3940(97)00470-9

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  12 in total

1.  Nociceptin reduces epileptiform events in CA3 hippocampus via presynaptic and postsynaptic mechanisms.

Authors:  M K Tallent; S G Madamba; G R Siggins
Journal:  J Neurosci       Date:  2001-09-01       Impact factor: 6.167

Review 2.  Nociceptin Opioid Receptor (NOP) as a Therapeutic Target: Progress in Translation from Preclinical Research to Clinical Utility.

Authors:  Nurulain T Zaveri
Journal:  J Med Chem       Date:  2016-03-14       Impact factor: 7.446

3.  Increased opioid receptor binding and G protein coupling in the accumbens and ventral tegmental area of postnatal day 2 rats.

Authors:  Yanning Hou; Mariana M Belcheva; Amy L Clark; Daniel S Zahm; Carmine J Coscia
Journal:  Neurosci Lett       Date:  2005-11-21       Impact factor: 3.046

4.  Orphanin FQ suppresses NMDA receptor-dependent long-term depression and depotentiation in hippocampal dentate gyrus.

Authors:  W Z Wei; C W Xie
Journal:  Learn Mem       Date:  1999 Sep-Oct       Impact factor: 2.460

5.  Nociceptin/orphanin FQ blockade of corticotropin-releasing factor-induced gamma-aminobutyric acid release in central amygdala is enhanced after chronic ethanol exposure.

Authors:  Maureen T Cruz; Melissa A Herman; Marsida Kallupi; Marisa Roberto
Journal:  Biol Psychiatry       Date:  2011-12-06       Impact factor: 13.382

Review 6.  [The endogenous opioid system and drug addiction].

Authors:  R Maldonado
Journal:  Ann Pharm Fr       Date:  2010-01-21

7.  A synthetic agonist at the orphanin FQ/nociceptin receptor ORL1: anxiolytic profile in the rat.

Authors:  F Jenck; J Wichmann; F M Dautzenberg; J L Moreau; A M Ouagazzal; J R Martin; K Lundstrom; A M Cesura; S M Poli; S Roever; S Kolczewski; G Adam; G Kilpatrick
Journal:  Proc Natl Acad Sci U S A       Date:  2000-04-25       Impact factor: 11.205

8.  Effect of novel nociceptin/orphanin FQ-NOP receptor ligands on ethanol drinking in alcohol-preferring msP rats.

Authors:  D Economidou; A Fedeli; R Martin Fardon; F Weiss; M Massi; R Ciccocioppo
Journal:  Peptides       Date:  2006-12       Impact factor: 3.750

Review 9.  Targeting opioid dysregulation in depression for the development of novel therapeutics.

Authors:  Caroline A Browne; Irwin Lucki
Journal:  Pharmacol Ther       Date:  2019-04-30       Impact factor: 12.310

10.  Postsynaptic mechanisms underlying responsiveness of amygdaloid neurons to nociceptin/orphanin FQ.

Authors:  S Meis; H C Pape
Journal:  J Neurosci       Date:  1998-10-15       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.